ArticleClinical proteomics2026
Inflammatory protein expression patterns in Hashimoto's thyroiditis: a cross-sectional observational study.
Article in Clinical proteomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of Vitamin D Levels and Systemic Inflammation in Patients with Hashimoto's Thyroiditis.Diseases (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe primary aim of this study is to gain insights into the immunopathogenesis of the most common autoimmune thyroid disorder, Hashimoto’s thyroiditis (HT). A secondary aim is to identify reliable protein biomarkers that can aid in the prediction of the presence and progression of HT, thus advancing disease monitoring and therapeutic development.
methodsThis cross-sectional study included 440 individuals − 267 HT patients and 173 healthy controls. HT patients were stratified based on disease severity into two subgroups: euthyroid/levothyroxine-treated (EUTHY-LT4) and hypothyroid (HYPO). Serum levels of 92 inflammation-related proteins were measured using the state-of-the-art Olink proteomics platform. Group comparisons were conducted using ANOVA and post hoc tests to identify differentially expressed proteins. The Boruta machine learning algorithm was applied to identify protein predictors of disease presence and severity.
resultsA total of 42 differentially expressed proteins were identified, revealing eight distinct expression patterns based on their direction of regulation across comparisons. IL-17C and CCL19 were the most upregulated in HT patients, and ST1A1, CASP-8, CXCL1, SIRT2, and LAP TGF-beta-1 were the most downregulated. An increased IL-17C/IL-10 ratio correlated with disease severity. Additionally, machine learning identified 22 protein markers with potential for distinguishing HT patients from controls, and 7 proteins for differentiating EUTHY-LT4 from HYPO patients.
conclusionsOur findings provide novel insights into the molecular landscape of immune-related protein changes in HT, highlighting a dynamic inflammatory response that varies with disease progression. These findings may contribute to the development of biomarkers for patient stratification, improved disease management, and targeted therapies to prevent or delay hypothyroidism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.